MDRX - MDRX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Veradigm Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm | Benzinga
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Veradigm Inc. (NASDAQ:MDRX) focused on whether Veradigm and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
If you have information that could assist in this investigation or if you are a Veradigm investor who suffered a loss and would like to learn more, you can provide your information here:
https://www.rgrdlaw.com/cases-veradigm-inc-investigation-mdrx.html
You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com.
THE COMPANY: Veradigm is a healthcare technology company that offers electronic health records, financial management, population health management, and consumer solutions to over 300,000 U.S. healthcare providers.
THE REVELATIONS: On February 28, 2023, Veradigm announced that it had "detected certain ...